Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
30/12/2025 22:24
Dec 30 (Reuters) - Neoimmunetech Inc 950220.KQ: EMMAUS LIFE SCIENCES INC - ENTERS LICENSE AND DISTRIBUTION AGREEMENT WITH NEOIMMUNETECH EMMAUS LIFE SCIENCES INC - GRANTS NIT EXCLUSIVE LICENSE TO MARKET, SELL AND DISTRIBUTE ENDARI IN U.S. AND CANADA EMMAUS LIFE SCIENCES INC - AGREEMENT INCLUDES UPFRONT PAYMENT AND ROYALTY ON NIT'S SALES Source text: ID:nBw3c9Wrza Further company coverage: 950220.KQ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neoimmunetech
See all newsBrief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Brief: Neoimmunetech To Conduct Capital Increase Of 65 Billion Won For Operational Funds
Brief: FDA Grants Orphan Drug Designation Status To NeoImmuneTech's NT-I7 For Advanced Pancreatic Cancer Treatment
Brief: FDA Grants Orphan Drug Tag to NeoImmuneTech's Acute Radiation Syndrome Treatment
Brief: Neoimmunetech Presents Phase 1 Study Data At Society For Neuro-Oncology Annual Meeting